We Help Companies Find New Sales Opportunities
Oxonica is to acquire Nanoplex Technologies, the US-based developer of nanoparticle-based detection systems for the healthcare and security markets with 17 staff.
Oxonica has raised £7.5m in a share placing on Aim to fund the development of new nanotechnology-based products.
Oxonica, the nanotechnology company, has raised £4m of venture capital to expand its sales and marketing activities.
Oxonica has raised £4.3m to fund the expansion of its nanoparticles business, which will enable it to double staff from 11 to 22 by the end of the year and find partners to help with the commercial development of the technology.